Public participation in assessing gene technology
We rigorously assess each application to release a GMO into the environment for risk to human health and safety and the environment. This involves writing a risk assessment and risk management plan (RARMP).
A RARMP is open to submission of comments for a minimum of 30 days. Experts, stakeholders and any member of the community can comment on a RARMP.
All comments are taken into consideration before the Gene Technology Regulator makes a decision about the application.
|Licence number||Project title||Organisation||Closing date|
Clinical trial with a genetically modified Bordetella pertussis for the prevention of whooping cough
Novotech (Australia) Pty Ltd
We are committed to making applications for licences and the subsequent risk assessments available to anyone who wants to see them. Contact us to get copies of any application for release of a GMO into the environment. You can also view the risk assessments we prepare for these applications.
We also occasionally ask for public comment on other matters such as proposed changes to the Regulator’s guidelines and policy documents, and reviews of the legislation.
Subscribe to OGTR news
Let us automatically notify you about:
- new licence applications for the release of GMOs into the environment
- public consultations
- significant changes to legislation.